Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ARDX
#2302
Ardelyx, Inc. - Common Stock
5.1
6
USD
0.00%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.39%
Monthly Change
-10.10%
6 month change
-26.91%
Year Change
+14.16%
Previous Close
5.1
4
Open
5.1
6
Low
5.1
6
High
5.1
6
Volume
166
Markets
US Stock Market
Healthcare
Biotechnology
ARDX
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Current
Key stats
Total common shares outstanding
239.26 M
240.98 M
242.97 M
245.25 M
247.03 M
247.03 M
Valuation ratios
Enterprise value
1.3 B
1.06 B
1.5 B
1.56 B
1.65 B
1.51 B
Price to earnings ratio
-21.35
-16.33
-22.96
-22.42
-24.96
-22.61
Price to sales ratio
3.2
2.4
3.3
3.45
3.39
3.07
Price to cash flow ratio
-24.55
17.56
24.61
-33.08
-40.39
-36.59
Price to book ratio
1.86
1.5
2.14
8.42
2.38
2.16
Enterprise value to EBITDA ratio
70.62
51.25
128.56
-41.26
-31.25
-32.64
Profitability ratios
Return on assets %
-0.1
-0.04
-0
-0
-0.07
-0.07
Return on equity %
-0.28
-0.14
-0.01
-0
-0.25
-0.25
Return on invested capital %
-86.22
-29.56
10.31
10.16
-61.39
-61.39
Gross margin %
83.4
87.3
96.39
91.34
94.91
94.91
Operating margin %
-49.04
-14.74
4.23
4.07
-34.71
-34.71
EBITDA margin %
-31.63
-1.39
8.66
-18.1
-33.74
-33.74
Net margin %
-55.51
-19.54
-0.88
-0.33
-39.81
-39.81
Liquidity ratios
Quick ratio
2.73
2.79
2.86
2.93
2.32
2.32
Current ratio
4.12
4.3
4.41
4.31
3.49
3.49
Inventory turnover
0.12
0.1
0.03
0.09
0.04
0.04
Asset turnover
0.18
0.21
0.23
0.25
0.19
0.19
Solvency ratios
Debt to assets ratio
0.37
0.43
0.42
0.4
0.4
0.4
Debt to equity ratio
1.04
1.44
1.31
1.21
1.37
1.37
Long term debt to total assets ratio
0.37
0.43
0.42
0.4
0.4
0.4
Long term debt to total equity ratio
1.04
1.44
1.31
1.21
1.37
1.37
Per share metrics
Operating cash flow per share
-0.16
-0.11
0
0.09
-0.13
-0.15
EBIT per share
-0.1
-0.01
0.04
-0.1
-0.13
-0.2
EBITDA per share
-0.1
-0.01
0.04
-0.09
-0.13
-0.19
Total debt per share
0.63
0.84
0.84
0.84
0.83
0.83
Cash per share
0.9
0.99
1
1.1
0.97
0.97
Net current asset value per share
1.31
1.47
1.52
1.59
1.55
1.55
Tangible book value per share
0.61
0.58
0.64
0.69
0.6
0.6
Working capital per share
0.99
1.12
1.18
1.22
1.11
1.11
Book value per share
0.61
0.58
0.64
0.69
0.6
0.6
News
Ardelyx Stock: The Market Is Right To Discount This Revenue Growth (NASDAQ:ARDX)
Aquestive Therapeutics (AQST) Moves 6.6% Higher: Will This Strength Last?
Ardelyx, Inc. (ARDX) Q1 2026 Earnings Call Transcript
Ardelyx (ARDX) Reports Q1 Loss, Beats Revenue Estimates
Compared to Estimates, Ardelyx (ARDX) Q1 Earnings: A Look at Key Metrics
Neurocrine Biosciences (NBIX) Reports Next Week: Wall Street Expects Earnings Growth
Will Ardelyx (ARDX) Report Negative Earnings Next Week? What You Should Know
Leerink Partners reiterates Ardelyx stock rating on pipeline progress
Ardelyx at Leerink Conference: Strategic Growth and Pipeline Focus
Ardelrx director David Mott buys $1.94m in shares
Ardelrx (ARDX) chief technical operations officer Bishop sells shares worth $18,586
Ardelyx SVP Reilly sells $29k in shares to cover tax obligations